Neogen Chemicals Ltd is Rated Strong Sell

Understanding the Current Rating

The Strong Sell rating assigned to Neogen Chemicals Ltd indicates a cautious stance for investors, signalling that the stock is expected to underperform relative to the broader market and its sector peers. This recommendation is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the company’s investment appeal and risk profile.

Quality Assessment

As of 11 January 2026, Neogen Chemicals holds an average quality grade. This suggests that while the company maintains a baseline operational standard, it faces challenges in delivering robust profitability and efficient capital utilisation. The average quality is reflected in its return on equity (ROE), which stands at 9.65% on average, indicating modest returns generated on shareholders’ funds. Additionally, the company’s ability to service its debt is limited, with a high Debt to EBITDA ratio of 4.01 times, signalling elevated financial risk and potential strain on cash flows.

Valuation Perspective

The stock is currently considered expensive relative to its capital employed, trading at an enterprise value to capital employed ratio of 2.2. This valuation metric suggests that investors are paying a premium for the company’s assets despite subdued profitability and growth prospects. Although the stock trades at a discount compared to its peers’ historical averages, the current valuation does not appear justified given the company’s financial performance and outlook. Investors should be wary of the premium valuation amid weakening fundamentals.

Financial Trend and Profitability

The financial trend for Neogen Chemicals is decidedly very negative. The company has reported negative results for two consecutive quarters, with the latest quarterly profit after tax (PAT) at ₹3.37 crores, representing a sharp decline of 68.5% compared to the previous four-quarter average. Operating profit growth over the past five years has been modest at an annual rate of 14.16%, but recent quarters show deteriorating margins and profitability. The return on capital employed (ROCE) is low at 5.9%, and the operating profit to interest coverage ratio has fallen to 1.54 times, indicating limited cushion to meet interest obligations. Over the past year, the stock has delivered a negative return of 47.91%, while profits have contracted by 12.7%, underscoring the challenging financial environment.

Technical Outlook

The technical grade for Neogen Chemicals is bearish, reflecting weak price momentum and negative investor sentiment. The stock’s recent price movements show volatility and underperformance relative to benchmark indices. For instance, the stock has declined 28.15% over six months and 24.23% over three months, with a year-to-date loss of 3.48%. This downward trend is consistent with the broader negative financial indicators and suggests limited near-term recovery potential.

Performance Relative to Market Benchmarks

Neogen Chemicals has underperformed the BSE500 index across multiple time frames, including the last three years, one year, and three months. This underperformance highlights the stock’s inability to keep pace with broader market gains and sectoral peers. The combination of weak returns, declining profitability, and elevated financial risk contributes to the cautious stance reflected in the Strong Sell rating.

Implications for Investors

For investors, the Strong Sell rating serves as a warning to exercise prudence. The company’s current fundamentals suggest that it faces significant headwinds, including high leverage, declining profits, and a challenging valuation environment. Investors should carefully consider these factors before initiating or maintaining positions in Neogen Chemicals. The rating implies that the stock may continue to face downward pressure and could underperform in the near to medium term.

Summary of Key Metrics as of 11 January 2026

• Debt to EBITDA ratio: 4.01 times (high leverage)


• Return on Equity (average): 9.65%


• Operating profit growth (5-year CAGR): 14.16%


• Quarterly PAT decline: -68.5%


• ROCE (half-year): 5.72%


• Operating profit to interest coverage (quarterly): 1.54 times


• Enterprise value to capital employed: 2.2 (expensive valuation)


• Stock returns: 1 day +1.89%, 1 month +16.61%, 3 months -24.23%, 6 months -28.15%, 1 year -47.91%

Sector and Market Context

Neogen Chemicals operates within the specialty chemicals sector, a space characterised by cyclical demand and sensitivity to raw material costs and regulatory changes. The company’s small-cap status adds an additional layer of volatility and liquidity risk. Compared to sector peers, Neogen Chemicals’ valuation and financial health lag behind, which further justifies the cautious rating. Investors seeking exposure to specialty chemicals may find more stable opportunities in companies with stronger balance sheets and consistent earnings growth.

Conclusion

In conclusion, Neogen Chemicals Ltd’s current Strong Sell rating by MarketsMOJO reflects a comprehensive evaluation of its financial health, valuation, quality, and technical outlook as of 11 January 2026. The company faces significant challenges including high leverage, declining profitability, and bearish price trends. Investors should approach the stock with caution, recognising the risks inherent in its current profile. This rating serves as a guide to help investors make informed decisions based on the latest available data rather than historical snapshots.

Unlock special upgrade rates for a limited period. Start Saving Now →